IRB #

IRB00010433

Title

A pilot study for the Varicella Zoster Vaccine (VERVE) Trial

Principal Investigator

Kevin Winthrop

Study Purpose

To evaluate the safety of the Zoster Vaccine in patients using Anti-TNF Therapies or abatacept

Medical Condition(s)

protection against shingles in individuals with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

Eligibility Criteria

50 years or older
have rheumatoid arthritis AND currently receiving an Anti-TNF therapy or abatacept

Age Range

50 - 95

Healthy Volunteers Needed

No

Duration of Participation

up to 1 year

Minors Included

No

Contact

Sarah Siegel 503 494 1384

Sponsor

Bristol Myers Squibb

Recruitment End

06/30/2017

Compensation Provided

Yes

Compensation

You will receive $25 for completing the screening visit, and $75 for six-week follow up visit. If you withdraw before the end of the study, you will be paid for the visits you have completed. If you complete the entire study, you will receive $100.


Go Back